Skip to main content

Table 1 Epidemiological findings of the study groups

From: Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country

Characteristic

PIs group

n (%)

PPCI group

n (%)

p

Age (in years) (median, IQR)

62 (52–70)

68 (59–75)

< 0.001

Male sex

84 (87.5)

70 (92.1)

0.453

Clinical Characteristics

   

 Hypertension

42 (43.7)

37 (48.7)

0.519

 Type 2 diabetes mellitus

26 (27.1)

14 (18.4)

0.182

 Dyslipidemia

42 (43.8)

39 (48.6)

0.519

 Smoking habit

21 (21.9)

28 (36.8)

0.031

 Chronic coronary syndrome

4 (4.2)

3 (3.9)

1.000

 Cerebrovascular disease

6 (6.3)

2 (2.6)

0.469

 Previous myocardial infarction

4 (4.2)

3 (3.9)

0.942

 Coronary revascularization

2 (2.1)

3 (3.9)

0.656

 Chronic kidney disease

5 (5.2)

5 (6.6)

0.751

 Chronic heart failure

0

1 (1.3)

0.442

  1. Categorical values are expressed in frequency and percentage (%)
  2. IQR interquartile range, PIs pharmacoinvasive strategy, PPCI primary percutaneous coronary intervention
  3. P value obtained using Pearson’s chi-square and Wilcoxon rank sum test according to the type of variables